Qinghua Xia

10PUBLICATIONS
17CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedMolecular targetsInnate immunityPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 29, 2023
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma

Jiechuan Qiu, Zicheng Wang, Peizhi Zhang

|Jul 01, 2022
ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway.

Peizhi Zhang, Yingkun Xu, Shaoan Chen

|Aug 06, 2021
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.

Hui Xiong, Hui Gao, Jinding Hu

|Dec 31, 2020
Corrigendum to "The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma".

Weiting Kang, Meng Zhang, Qiang Wang

|Dec 31, 2020
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes.

Yingkun Xu, Guangzhen Wu, Xue Ma

|Oct 08, 2020
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma.

Yingkun Xu, Xiunan Li, Yuqing Han

Pageof 2

Frequent Collaborators

6 joint publications

Guangzhen Wu

4 joint publications

Yingkun Xu

3 joint publications

Weiting Kang

3 joint publications

Hanbo Wang